Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1453)
All Articles published online
|
Sep 14, 2006 (publication date) through May 7, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gupta R, Ramakrishna C, Lakhtakia S, Tandan M, Banerjee R, Reddy DN. Efficacy of low dose peginterferon alpha-2b with ribavirin on chronic hepatitis C. World J Gastroenterol 2006; 12(34): 5554-5556 [PMID: 17006999 DOI: 10.3748/wjg.v12.i34.5554] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i34/5554.htm |
| Number | Citing Articles |
| 1 |
Zehui Yan, Ke Fan, Xiaohong Wang, Qing Mao, Guohong Deng, Yuming Wang. Efficacy and Safety of Low-Dose Peginterferon Alpha-2a Plus Ribavirin on Chronic Hepatitis C. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/302093
|
| 2 |
Nathan Ford, Catherine Kirby, Kasha Singh, Edward J Mills, Graham Cooke, Adeeba Kamarulzaman, Philipp duCros. Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis. Bulletin of the World Health Organization 2012; 90(7): 540 doi: 10.2471/BLT.11.097147
|
| 3 |
Manav Wadhawan, Sunil Taneja, Rajeev Shandil, Neerav Goyal, Subash Gupta, Ajay Kumar. Management of chronic hepatitis C before and after liver transplant. Apollo Medicine 2012; 9(1): 24 doi: 10.1016/S0976-0016(12)60116-1
|
| 4 |
Qunying Han, Zhengwen Liu, Wen Kang, Han Li, Lei Zhang, Ni Zhang. Interferon Beta 1a versus Interferon Beta 1a plus Ribavirin for the Treatment of Chronic Hepatitis C in Chinese Patients: A Randomized, Placebo-Controlled Trial. Digestive Diseases and Sciences 2008; 53(8): 2238 doi: 10.1007/s10620-007-0129-2
|
| 5 |
Ajit Sood, Vandana Midha, Omesh Goyal, Syed Hissar, Suresh Kumar Sharma, Pankaj Khanna. Treatment of chronic hepatitis C with pegylated interferon plus ribavirin in treatment-naïve ‘real-life’ patients in India. Indian Journal of Gastroenterology 2014; 33(4): 343 doi: 10.1007/s12664-014-0451-5
|
| 6 |
Deepinder Kaur, Rajoo Singh Chhina, Omesh Goyal, Prerna Goyal. Treatment results and factors affecting sustained virological response in chronic hepatitis C patients in Northern India. Journal of Gastrointestinal Infections 2015; 5(1): 24 doi: 10.5005/jp-jogi-5-1-24
|
| 7 |
Ijaz S Jamall, Shafaq Yusuf, Maimoona Azhar, Selene Jamall. Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2/3?. World Journal of Gastroenterology 2008; 14(43): 6627-6631 doi: 10.3748/wjg.14.6627
|
| 8 |
Ajit Sood, Vandana Midha, Varun Mehta, Sarit Sharma, Rasham Mittal, Amandeep Thara, Neena Sood, Amarjeet Kaur. How sustained is sustained viral response in patients with hepatitis C virus infection?. Indian Journal of Gastroenterology 2010; 29(3): 112 doi: 10.1007/s12664-010-0006-3
|